United Kingdom Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

  • ID: 4334443
  • Report
  • Region: United Kingdom, Great Britain
  • 213 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Boston Scientif
  • DePuy Synthes Inc
  • KARL STORZ GmbH & Co KG
  • LivaNova PLC
  • Medtronic Plc
  • MORE
United Kingdom Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

Summary

The new report, "United Kingdom Neurology Devices Market Outlook to 2023", provides key market data on the United Kingdom Neurology Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the United Kingdom Neurology Devices market.
  • Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC, LivaNova PLC and Others.
Reasons to Buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Boston Scientif
  • DePuy Synthes Inc
  • KARL STORZ GmbH & Co KG
  • LivaNova PLC
  • Medtronic Plc
  • MORE
1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Introduction
2.1 What Is This Report About?
2.2 Neurology Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3. Neurology Devices Market, United Kingdom
3.1 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2023
3.2 Neurology Devices Market, United Kingdom, Revenue ($m), 2009-2016
3.5 Neurology Devices Market, United Kingdom, Revenue ($m), 2016-2023
3.6 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023
3.7 Neurology Devices Market, United Kingdom, Volume (Units), 2009-2016
3.8 Neurology Devices Market, United Kingdom, Volume (Units), 2016-2023
3.9 Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
4. CSF Management Market, United Kingdom
4.1 CSF Management Market, United Kingdom, Revenue Mix ($m), 2016
4.2 CSF Management Market, United Kingdom, Segment Contribution (%), 2016
4.3 CSF Management Market, United Kingdom, Revenue ($m), 2009-2016
4.4 CSF Management Market, United Kingdom, Revenue ($m), 2016-2023
4.5 CSF Management Market, United Kingdom, Volume (Units), 2009-2016
4.6 CSF Management Market, United Kingdom, Volume (Units), 2016-2023
4.7 CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
4.8 CSF Management Market, United Kingdom, Company Share by Revenue ($m), 2016
5. Interventional Neurology Market, United Kingdom
5.1 Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016
5.2 Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016
5.3 Interventional Neurology Market, United Kingdom, Revenue ($m), 2009-2016
5.4 Interventional Neurology Market, United Kingdom, Revenue ($m), 2016-2023
5.4.1 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2009-2016
5.4.2 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2009-2016
5.4.3 Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), by Segment, 2016-2023
5.4.4 Navigational System Market, United Kingdom, Revenue ($m), by Segment, 2016-2023
5.5 Interventional Neurology Market, United Kingdom, Volume (Units), 2009-2016
5.6 Interventional Neurology Market, United Kingdom, Volume (Units), 2016-2023
5.6.1 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2009-2016
5.6.2 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2009-2016
5.6.3 Embolization and Coiling Devices Market, United Kingdom, Volume (Units), by Segment, 2016-2023
5.6.4 Navigational System Market, United Kingdom, Volume (Units), by Segment, 2016-2023
5.7 Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
5.8 Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), 2016
6. Neurological Diagnostic Equipment Market, United Kingdom
6.1 Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016
6.2 Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016
6.3 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2009-2016
6.4 Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), 2016-2023
6.5 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2009-2016
6.6 Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), 2016-2023
6.7 Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
6.8 Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), 2016
7. Neurostimulation Devices Market, United Kingdom
7.1 Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016
7.2 Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016
7.3 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2009-2016
7.4 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2016-2023
7.5 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2009-2016
7.6 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2016-2023
7.7 Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
7.8 Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
8. Neurosurgical Products Market, United Kingdom
8.1 Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016
8.2 Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016
8.3 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2009-2016
8.4 Neurosurgical Products Market, United Kingdom, Revenue ($m), 2016-2023
8.5 Neurosurgical Products Market, United Kingdom, Volume (Units), 2009-2016
8.6 Neurosurgical Products Market, United Kingdom, Volume (Units), 2016-2023
8.7 Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
8.8 Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), 2016
9. Radiosurgery Market, United Kingdom
9.1 Radiosurgery Market, United Kingdom, Revenue ($m), 2009-2016
9.2 Radiosurgery Market, United Kingdom, Revenue ($m), 2016-2023
9.3 Radiosurgery Market, United Kingdom, Volume (Units), 2009-2016
9.4 Radiosurgery Market, United Kingdom, Volume (Units), 2016-2023
10 Overview of Key Companies in United Kingdom, Neurology Devices Market
10.1 Medtronic Plc
10.1.1 Company Overview
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.3 Stryker Corporation
10.3.1 Company Overview
10.4 DePuy Synthes Inc
10.4.1 Company Overview
10.5 KARL STORZ GmbH & Co KG
10.5.1 Company Overview
10.6 Integra LifeSciences Holdings Corp
10.6.1 Company Overview
10.7 Natus Medical Incorporated
10.7.1 Company Overview
10.8 Terumo Corp
10.8.1 Company Overview
10.9 St. Jude Medical LLC
10.9.1 Company Overview
10.10 LivaNova PLC
10.10.1 Company Overview
10.11 Boston Scientific Corp
10.11.1 Company Overview
10.12 Sophysa SA
10.12.1 Company Overview
11 Neurology Devices Market Pipeline Products
12 Financial Deals Landscape
12.1 Acquisition
12.1.1 Nestle Health Science to Acquire Phagenesis
12.2 Equity Offerings
12.2.1 Belluscura Raises USD0.7 Million in Second Tranche of Private Placement
12.3 Partnerships
12.3.1 York Instruments Enters into Agreement with eemagine Medical Imaging Solutions
12.3.2 GlaxoSmithKline to Form Joint Venture with Verily Life Sciences
12.4 Venture Financing
12.4.1 Cerus Endovascular Raises USD2.4 Million in Venture Financing
13 Recent Developments
13.1 Corporate Communications
13.1.1 Jun 19, 2017: GSK confirms start date for Luke Miels
13.1.2 Jun 15, 2017: Magstim Group Appoints Lothar Krinke as New CEO
13.1.3 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel
13.1.4 May 24, 2017: Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference
13.1.5 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer
13.1.6 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation
13.1.7 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
13.1.8 Jan 19, 2017: Abbas Hussain to leave GSK
13.1.9 Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
13.1.10 Jan 17, 2017: IXICO appoints Giulio Cerroni as Chief Executive Officer
13.1.11 Dec 19, 2016: GSK announces Board changes
13.1.12 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester
13.1.13 Oct 14, 2016: AorTech International Announces Board Changes
13.1.14 Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare
13.1.15 Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline
13.1.16 Sep 16, 2016: IXICO: Board Changes
13.1.17 Sep 16, 2016: Guy's and St Thomas' NHS Foundation Trust: New Non-Executive Director appointed
13.1.18 Aug 09, 2016: Guy's and St Thomas' appoints Chief Operating Officer
13.1.19 Aug 05, 2016: Two new Non-Executive Directors join the Board of Directors
13.1.20 Aug 01, 2016: LivaNova Names Chief Operating Officer
13.1.21 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors
13.1.22 Jul 27, 2016: BTG Announces Appointment of Non-executive Director
13.1.23 Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award
13.2 Financial Announcements
13.2.1 May 22, 2017: IXICO: Half Yearly Report to 31 March 2017
13.2.2 May 03, 2017: Casmed Reports First-Quarter 2017 Financial Results
13.2.3 May 03, 2017: LivaNova Reports First Quarter 2017 Results
13.2.4 Apr 26, 2017: GSK delivers another quarter of continued progress
13.2.5 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance
13.2.6 Mar 29, 2017: Cambridge Cognition Holdings: Preliminary Results for the year ended 31 December 2016
13.2.7 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results
13.2.8 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
13.2.9 Dec 21, 2016: AorTech International: Unaudited Interim Results For the six months ended 30 September 2016
13.2.10 Nov 15, 2016: BTG: Interim results
13.2.11 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results
13.2.12 Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
13.2.13 Sep 29, 2016: LivaNova Announces Half-Year Financial Report
13.2.14 Sep 22, 2016: Cambridge Cognition Holdings: Half Yearly Report
13.2.15 Aug 15, 2016: AorTech International: Audited results for the year ended 31 March 2016
13.2.16 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results
13.2.17 Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016
13.3 Government and Public Interest
13.3.1 Dec 02, 2016: Improving Alzheimer’s Disease Research with Digital Health Technology
13.3.2 Sep 28, 2016: New Clinical Study on NeuroEyeCoach Conclusively Supports Meaningful Improvement in Eye Movement Efficiency
13.4 Legal And Regulatory
13.4.1 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange
13.4.2 Dec 21, 2016: AorTech Shares Dive As Losses And Lawsuit Against Former CEO Continue
13.5 Other Significant Developments
13.5.1 Jun 07, 2017: Cambridge Cognition Holdings: Speech recognition for clinical trials
13.5.2 Apr 11, 2017: Stroke patients in England set to receive revolutionary new treatment
13.5.3 Dec 13, 2016: Magstim announces new distribution partnership in Netherlands
13.5.4 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
13.5.5 Oct 06, 2016: BTG: close period update
13.5.6 Sep 29, 2016: University of Glasgow to share in £17.7 million funding for new healthcare technologies research
13.5.7 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions
13.5.8 Jul 27, 2016: GSK announces significant new investment in UK manufacturing network
13.5.9 Jul 14, 2016: BTG: Annual General Meeting
13.5.10 Jul 14, 2016: North Bristol NHS Trust wins innovation award to improve quality of health care
13.5.11 Jul 08, 2016: New funding for the harmonisation and alignment of brain imaging methods
13.6 Product News
13.6.1 May 18, 2017: Renishaw presents implant technology for oral and maxillofacial surgeons
13.6.2 Feb 23, 2017: Renishaw exhibiting at BioWales 2017
13.6.3 Jul 15, 2016: Alzheimer’s Association International Conference 2016
13.7 Strategy And Business Planning
13.7.1 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
13.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation
13.7.3 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization
14 Appendix
14.1 Research Methodology
14.1.1 Coverage
14.1.2 Secondary Research
14.1.3 Primary Research
14.1.4 Company Share Analysis
14.1.5 Distribution Share Analysis
14.1.6 Benchmarking
14.2 Consulting
14.3 Contact Us
14.4 Disclaimer

1.1 List of Tables
Table 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023
Table 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023
Table 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 7: Neurology Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 8: CSF Management Market, United Kingdom, Segment Contribution (%), 2016
Table 9: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 11: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 12: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 13: CSF Management Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 14: CSF Management Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 15: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016
Table 16: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 18: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 20: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 21: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 22: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 23: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 24: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 25: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 26: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 27: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 28: Interventional Neurology Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 29: Interventional Neurology Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 30: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016
Table 31: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 33: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 35: Neurological Diagnostic Equipment Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 37: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016
Table 38: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 42: Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016
Table 45: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 47: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 49: Neurosurgical Products Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 50: Neurosurgical Products Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 55: Neurology Devices Market Pipeline Products
Table 56: Nestle Health Science to Acquire Phagenesis
Table 57: Belluscura Raises USD0.7 Million in Second Tranche of Private Placement
Table 58: York Instruments Enters into Agreement with eemagine Medical Imaging Solutions
Table 59: GlaxoSmithKline to Form Joint Venture with Verily Life Sciences
Table 60: Cerus Endovascular Raises USD2.4 Million in Venture Financing

1.2 List of Figures
Figure 1: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, 2009-2023
Figure 2: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 3: Neurology Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 4: Neurology Devices Market, United Kingdom, Volume (Units), 2009-2023
Figure 5: Neurology Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 6: Neurology Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 7: Neurology Devices Market, United Kingdom, Company Share (%) 2016
Figure 8: CSF Management Market, United Kingdom, Revenue Mix ($m), 2016
Figure 9: CSF Management Market, United Kingdom, Segment Contribution (%), 2016
Figure 10: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 11: CSF Management Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 12: CSF Management Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 13: CSF Management Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 14: CSF Management Market, United Kingdom, Company Share (%) 2016
Figure 15: Interventional Neurology Market, United Kingdom, Revenue Mix ($m), 2016
Figure 16: Interventional Neurology Market, United Kingdom, Segment Contribution (%), 2016
Figure 17: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 18: Interventional Neurology Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 19: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 20: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Embolization and Coiling Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Navigational System Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 23: Interventional Neurology Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 24: Interventional Neurology Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 25: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 26: Navigational System Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 27: Embolization and Coiling Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 28: Navigational System Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 29: Interventional Neurology Market, United Kingdom, Company Share (%) 2016
Figure 30: Neurological Diagnostic Equipment Market, United Kingdom, Revenue Mix ($m), 2016
Figure 31: Neurological Diagnostic Equipment Market, United Kingdom, Segment Contribution (%), 2016
Figure 32: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 33: Neurological Diagnostic Equipment Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 34: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 35: Neurological Diagnostic Equipment Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 36: Neurological Diagnostic Equipment Market, United Kingdom, Company Share (%) 2016
Figure 37: Neurostimulation Devices Market, United Kingdom, Revenue Mix ($m), 2016
Figure 38: Neurostimulation Devices Market, United Kingdom, Segment Contribution (%), 2016
Figure 39: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 40: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 41: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 42: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 43: Neurostimulation Devices Market, United Kingdom, Company Share (%) 2016
Figure 44: Neurosurgical Products Market, United Kingdom, Revenue Mix ($m), 2016
Figure 45: Neurosurgical Products Market, United Kingdom, Segment Contribution (%), 2016
Figure 46: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 47: Neurosurgical Products Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 48: Neurosurgical Products Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 49: Neurosurgical Products Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 50: Neurosurgical Products Market, United Kingdom, Company Share (%) 2016
Figure 51: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 52: Radiosurgery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 53: Radiosurgery Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 54: Radiosurgery Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic Plc
  • B. Braun Melsungen AG
  • Stryker Corporation
  • DePuy Synthes Inc
  • KARL STORZ GmbH & Co KG
  • Integra LifeSciences Holdings Corp
  • Natus Medical Incorporated
  • Terumo Corp
  • St. Jude Medical LLC
  • LivaNova PLC
  • Boston Scientif
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll